摘要
目的分析长春西汀治疗CCCI(慢性脑供血不足)的临床治疗疗效。方法纳入本院自2017年3月—2018年3月收治的CCCI患者200例,以"入院顺序奇偶性"平均分为两组,对照组47例患者采纳脑保护、营养脑神经、抗血小板凝聚等基础治疗,观察组47例患者在对照组基础上予以长春西汀治疗,对比两组临床疗效、血液流速指标。结果观察组临床总有效率(97.00%)显著比对照组(82.00%)高,观察组治疗2周后BA、LVA、RVA水平均显著显著比对照组高,差异均具有统计学意义(P <0.05)。结论长春西汀可有效改善CCCI患者耳鸣、头晕等症状,提高血液流速,临床价值较高。
Objective To analyze the clinical efficacy of vinpocetine in the treatment of CCCI(chronic cerebral insufficiency).Methoded 200 patients with CCCI admitted to our hospital from March 2017 to March 2018 were divided into 2 groups according to the“parity of admission order”.47 patients in the control group adopted brain protection,nutritional cranial nerve,anti-platelet aggregation,etc.In the basic treatment,47 patients in the observation group were treated with vinpocetine on the basis of the control group,and the clinical efficacy and blood flow rate index of the two groups were compared.Results The clinical total effective rate of the observation group(97.00%)was significantly higher than that of the control group(82.00%).The levels of Ba,LVA and RVA in the observation group after 2 weeks of treatment were significantly higher than those of the control group,and the differences were statistically significant(P<0.05).Conclusion Vinpocetine can effectively improve symptoms such as tinnitus and dizziness in patients with CCCI,improve blood flow rate,and have higher clinical value.
作者
邹敏
杨涛
ZOU Min;YANG Tao(Department of Encephalology,Yingcheng Hospital of Traditional Chinese Medicine,Yingcheng Hubei 432300,China)
出处
《中国继续医学教育》
2020年第26期147-150,共4页
China Continuing Medical Education
